Deep Learning Model and Risk Factors for Tacrolimus-related Acute Kidney Injury

Active, not recruitingOBSERVATIONAL

Enrollment

1,200

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

September 1, 2026

Study Completion Date

December 30, 2026

Conditions

AKI

Trial Locations (1)

The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan

All Listed Sponsors

lead

Qianfoshan Hospital

OTHER

NCT06596798 - Deep Learning Model and Risk Factors for Tacrolimus-related Acute Kidney Injury | Biotech Hunter | Biotech Hunter